Humana price target raised to $345 from $300 at Mizuho

Mizuho analyst Ann Hynes raised the firm’s price target on Humana (HUM) to $345 from $300 and keeps an Outperform rating on the shares. The firm adjusted price targets in the healthcare facility and managed care space following an analysis of Medicare Advantage star ratings. The target changes are driven by increased earnings visibility on key issues along with the overall rotation into the healthcare sector, the analyst tells investors in a research note.